CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 237 filers reported holding CLOVIS ONCOLOGY INC in Q1 2017. The put-call ratio across all filers is 0.73 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2018 | $2,501,000 | +5.1% | 55,000 | +57.1% | 0.96% | +8.9% |
Q4 2017 | $2,380,000 | -3.7% | 35,000 | +16.7% | 0.88% | +5.0% |
Q3 2017 | $2,472,000 | +32.0% | 30,000 | +50.0% | 0.84% | +22.6% |
Q2 2017 | $1,873,000 | +47.1% | 20,000 | 0.0% | 0.69% | +15.7% |
Q1 2017 | $1,273,000 | +91.1% | 20,000 | +33.3% | 0.59% | +86.5% |
Q4 2016 | $666,000 | – | 15,000 | – | 0.32% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Healthcare Value Capital, LLC | 250,000 | $1,200,000 | 4.04% |
Palo Alto Investors LP | 4,469,411 | $21,453,000 | 1.12% |
ARMISTICE CAPITAL, LLC | 2,256,000 | $10,829,000 | 0.37% |
Vigilare Wealth Management | 32,200 | $155,000 | 0.15% |
Ikarian Capital, LLC | 650,000 | $3,121,000 | 0.14% |
Ikarian Capital, LLC | 642,108 | $3,082,000 | 0.14% |
WELD CAPITAL MANAGEMENT LLC | 40,156 | $193,000 | 0.08% |
PINNACLE ASSOCIATES LTD | 703,970 | $3,379,000 | 0.07% |
Versant Venture Management, LLC | 101,855 | $489,000 | 0.05% |
Kalos Management, Inc. | 23,750 | $114,000 | 0.05% |